In contrast, within the non-failing (control) group, 39 samples were identified with MYH6/MYH7 ratios below the established threshold, indicating that based solely on this transcript ratio, these samples are essentially indistinguishable from those in the DCM cohort. The gene discussed is MYH6; the disease is familial dilated cardiomyopathy.